About 80% of people who have lung cancer have non-small-cell lung cancer. NSCLC usually spreads more slowly than small-cell lung cancers. Both cancers affect the lungs and have similar symptoms ...

American Cancer Society: “How is non-small cell lung cancer staged?” “Surgery for non-small cell lung cancer,” “Treatment choices by stage for non-small cell lung cancer,” “Radiation ...

First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended ...

Lung cancer remains a severe malignancy, expected to account for over 125,000 deaths in 2024.  With high rates of mortality ...

A study of patients with metastatic lung cancer by researchers based in Brazil and the United States has found that their ...

A new case report was published in Oncoscience (Volume 11) on October 8, 2024, entitled, “Complete and long-lasting response ...

Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune Lua® for ...

The following is a summary of “Association of mutation profiles with metastasis in patients with non-small cell lung cancer,” ...

Analysis - Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It ...

BioNTech's Phase 3 NSCLC trial is paused after varying outcomes. Current participants continue treatment, and other trials ...

There are no approved therapies to tackle c-Met protein overexpression, AbbVie said in a press release. C-Met is a receptor ...

The work presented will be of interest to cancer biologists and more broadly to those interested in NSCLC translational studies. Non-small cell lung cancer (NSCLC) is the most common subtype of lung ...